A three-year clinical trial seeks to find out if a simple blood test can detect cancer in senior citizens. The post Can a ...

Guardant co-CEO Helmy Eltoukhy says the shift to personalized treatment and earlier diagnosis is here at the WIRED Health ...

Researchers hope to improve survival rates through early detection with a blood test that can detect over 50 types of cancer.

A UAE hospital is making early cancer detection easier and more accessible with a simple blood test that can spot more than ...

Galleri is a blood test that aims to detect over 50 types of cancer early. It analyzes cell-free DNA (cfDNA) and methylation patterns to identify potential cancer signals. The test is intended for ...

Forbes contributors publish independent expert analyses and insights. Greg Licholai writes and teaches about innovation in healthcare. It should be noted that the Galleri test not currently ...

"No cancer signal detected." The blood test results popped up in my online health portal without much fanfare. A doctor would chat about them with me later, congratulating me on the "phew"-worthy ...

A blood test for more than 50 types of cancer could significantly boost early detection and speed up diagnosis, according to a new study. Made by U.S. pharmaceutical company Grail, the Galleri test ...

Exact Science’s Michelle Beidelschies, PhD, reveals how a multi-biomarker class multi-cancer early detection test (MCED) blood test can help health systems expand detection across more cancers earlier ...

Finding the perfect early screening test for cancer remains a persistent challenge for the health industry. But new findings suggest that blood tests still being assessed are showing promising results ...

Jack Welter didn’t feel sick when he agreed to take a new blood test that looks for multiple types of cancer. But, approaching 60, he thought it couldn’t hurt. To his surprise, the test came back ...

Some claim the new multi-cancer detection tests will “revolutionize” cancer screening. Others fear the “worried well” will succumb to slick marketing and subpar tests and overwhelm both primary care ...